Market Research Reports

Breast Imaging Market (Mammography, Breast MRI, Breast Ultrasound, Tomosynthesis, Nuclear Imaging and Others Breast Thermography & Bioelectric Imaging) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

76pages
Published Date: 2014-04-07

Description



The global breast imaging market is developing at a rapid pace on account of high incidence of breast cancer across the globe. Women over 40 years of age are more susceptible to breast cancer, therefore, the rise in the geriatric population base is expected to fuel the growth of the breast imaging market significantly in the coming years.

The report analyzes the global breast imaging market on two fronts: technologies employed and geographical distribution. Based on technology, the global breast imaging market is classified into mammography, breast ultrasound, breast MRI, tomosynthesis, nuclear imaging, and others. Geographically, the market is spread across North America, Europe, Asia Pacific, and the Rest of the World.

The research report provides a comparative analysis of the global breast imaging market, including qualitative as well as quantitative evaluation of each segment of this market. The study also assesses the market dynamics and prevalent trends such as the growth drivers, limitations, and prospects influencing the current performance and the future status of this industry.

Overview of the global breast imaging market

The global market for breast imaging is majorly driven by the rise in prevalence of breast cancer worldwide. Additionally, initiatives by several governments to spread awareness regarding breast cancer are propelling the growth of the breast imaging market in the global arena. In 2012, the market stood at US$1.84 billion. Analysts expect the market to rise at a CAGR of 12% during the period from 2013 to 2019 and reach US$4.06 billion by 2019.

Among the technology segments of the global breast imaging industry, the markets for nuclear imaging and tomosynthesis are expected to experience robust growth in the near future, wherein the tomosynthesis market is projected to expand at a CAGR of 18.1% during the forecast period. Additionally, the market for ultrasound is expected to report impressive growth on account of its accuracy in detection of cancer.

Regionally, the breast imaging market in North America led the global industry with a share of 32.6% in 2012. On the account of highly developed medical and healthcare infrastructure and a well-organized regulatory structure, the market in North America is estimated to maintain its dominance over the forecast period. Furthermore, the breast imaging market in Asia Pacific is poised to expand at a healthy growth rate owing to the emerging medical tourism market in the region.

Overall, breast imaging market seems set to develop at a steady pace between 2013 and 2019, but the strict regulatory procedures to gain approval, coupled with less favorable reimbursement policies, are expected to hamper the growth of this market in the near future.

Companies mentioned in the research report 

The major participants operating in the global breast imaging market are Aurora Imaging Technologies Inc., FUJIFILM SonoSite, Inc., Dilon Technologies, Inc., GE Healthcare Ltd., Philips Healthcare, Hologic, Inc., SonoCine Inc., and Siemens Healthcare Corp.

In 2013, the U.S.-based Hologic, Inc. led the global mammography market. In the recent past, the firm has expanded its research and development capabilities and has had an increase in new product launches. The frequency of strategic partnerships and agreements has also been raised to maintain its dominance in the global breast imaging market.

Key segments of the breast imaging market based on technology:
  • Mammography
  • Breast Ultrasound
  • Breast MRI
  • Tomosynthesis
  • Nuclear Imaging
  • Others
Major geographies analyzed under this research report are: 
  • Europe
  • North America 
  • Asia-Pacific 
  • Rest of the World 
This report gives you access to decisive data such as:
  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for the coming years 
Key highlights of this report
  • Overview of key market forces propelling and restraining market growth 
  • Up-to-date analyses of market trends and technological improvements 
  • Pin-point analyses of market competition dynamics to offer you a competitive edge
  • An analysis of strategies of major competitors 
  • An array of graphics and SWOT analysis of major industry segments 
  • Detailed analyses of industry trends
  • A well-defined technological growth map with an impact-analysis 
  • Offers a clear understanding of the competitive landscape and key product segments

Table of Contents


Table of Contents

Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.4 List of Abbreviations

Chapter 2 Executive Summary
2.1 Market Snapshot: Global Breast Imaging Market
2.2 Comparative Analysis: Global Breast Imaging Market, By Geography, 2012 & 2019 (Value %)

Chapter 3 Market Overview
3.1 Overview – Current Market Scenario and Future Market Trends
3.2 Market Drivers
      3.2.1 High Incidence of Breast Cancer and Aging Demographics
      3.2.2 Government Initiative to Spread Awareness
3.3 Market Restraints
      3.3.1 Stringent Regulatory Approval Procedures
      3.3.2 Lack of Awareness
      3.3.3 Lack of Reimbursement Coverage
3.4 Market Opportunities
      3.4.1 Economic and Infrastructural Development in Emerging Countries
      3.4.2 Development Of Improved Technologies With Reduced Radiation Exposure
3.5 Porter’s Five Force Analysis for the Global Breast Imaging Market
      3.5.1 Bargaining Power of Suppliers
      3.5.2 Bargaining Power of Buyers
      3.5.3 Threat of New Entrants
      3.5.4 Threat of Substitutes
      3.5.5 Competitive Rivalry
3.6 Market Attractiveness Analysis: Global Breast Imaging Market, by Geography
3.7 Competitive Landscape
      3.7.1 Heat Map Analysis for Key Players of the Global Breast Imaging Market

Chapter 4 Global Breast Imaging Market, by Technology
4.1 Overview – Current Market Scenario and Future Market Trends
      4.1.1 Global Breast Imaging Market Revenue, by Technology, 2011 – 2019 (USD Million)
      4.1.2 Comparative Analysis: Global Breast Imaging Market, by Technology, 2012 & 2019 (Value %)
      4.1.3 Mammography
               4.1.3.1 Global Mammography Market Revenue, 2011 – 2019 (USD Million)
      4.1.4 Breast MRI
               4.1.4.1 Global Breast MRI Market Revenue, 2011 – 2019 (USD Million)
      4.1.5 Breast Ultrasound
               4.1.5.1 Global Breast Ultrasound Market Revenue, 2011 – 2019 (USD Million)
      4.1.6 Tomosynthesis
               4.1.6.1 Global Tomosynthesis Market Revenue, 2011 – 2019 (USD Million)
      4.1.7 Nuclear Imaging
               4.1.7.1 Global Nuclear Imaging Market Revenue, 2011 – 2019 (USD Million)
      4.1.8 Others
               4.1.8.1 Bioelectric Imaging
               4.1.8.2 Breast Thermography
               4.1.8.3 Global Other Breast Imaging Technologies Market Revenue, 2011 – 2019 (USD Million)

Chapter 5 Global Breast Imaging Market, by Geography
5.1 Overview – Current Market Scenario and Future Market Trends
      5.1.1 Global Breast Imaging Market Revenue, by Geography, 2011 - 2019 (USD Million)
5.2 North America
      5.2.1 North America Breast Imaging Market Revenue, 2011 - 2019 (USD Million)
      5.2.2 North America Breast Imaging Market Revenue, by Technology, 2011- 2019 (USD Million)
5.3 Europe
      5.3.1 Europe Breast Imaging Market Revenue, 2011 – 2019 (USD Million)
      5.3.2 Europe Breast Imaging Market Revenue, by Technology, 2011- 2019 (USD Million)
5.4 Asia-Pacific
      5.4.1 Asia-Pacific Breast Imaging Market Revenue, 2011 – 2019 (USD Million)
      5.4.2 Asia-Pacific Breast Imaging Market Revenue, by Technology, 2011- 2019 (USD Million)
5.5 Rest of the World (RoW)
      5.5.1 RoW Breast Imaging Market Revenue, 2011 – 2019 (USD Million)
      5.5.2 RoW Breast Imaging Market Revenue, by Technology, 2011- 2019 (USD Million)

Chapter 6 Recommendations
6.1 Investing in emerging markets
6.2 Incorporate cost containment measures
6.3 R&D excellence

Chapter 7 Company Profiles
7.1 Aurora Imaging Technologies, Inc.
      7.1.1 Company Overview
      7.1.2 Product Portfolio
      7.1.3 Business Strategies
      7.1.4 Recent Developments
7.2 Dilon Technologies, Inc.
      7.2.1 Company Overview
      7.2.2 Product Portfolio
      7.2.3 Business Strategies
7.3 FUJIFILM SonoSite, Inc.
      7.3.1 Company Overview
      7.3.2 Financial Overview
      7.3.3 Product Portfolio
      7.3.4 Business Strategies
      7.3.5 Recent Developments
7.4 GE Healthcare Ltd.
      7.4.1 Company Overview
      7.4.2 Financial Overview
      7.4.3 Product Portfolio
      7.4.4 Business Strategies
      7.4.5 Recent Developments
7.5 Hologic, Inc.
      7.5.1 Company Overview
      7.5.2 Financial Overview
      7.5.3 Product Portfolio
      7.5.4 Business Strategies
      7.5.5 Recent Developments
7.6 Philips Healthcare
      7.6.1 Company Overview
      7.6.2 Financial Overview
      7.6.3 Product Portfolio
      7.6.4 Business Strategies
      7.6.5 Recent Developments
7.7 Siemens Healthcare Corporation
      7.7.1 Company Overview
      7.7.2 Financial Overview
      7.7.3 Product Portfolio
      7.7.4 Business Strategies
      7.7.5 Recent Developments
7.8 SonoCine Inc.
      7.8.1 Company Overview
      7.8.2 Business Strategies

List of Figures

FIG. 1 Breast Imaging Market Segmentation
FIG. 2 Global Breast Imaging Market Revenue, by Technology, 2012 (USD Million)
FIG. 3 Comparative Analysis: Global Breast Imaging Market, by Geography, 2012 & 2019 (Value %)
FIG. 4 Porter’s Five Force Analysis: Global Breast Imaging Market
FIG. 5 Market Attractiveness Analysis: Global Breast Imaging Market, by Geography
FIG. 6 Heat Map Analysis for Key Players of the Global Breast Imaging Market
FIG. 7 Comparative Analysis: Global Breast Imaging Market, by Technology, 2012 & 2019 (Value %)
FIG. 8 Global Mammography Market Revenue, 2011 – 2019 (USD Million)
FIG. 9 Global Breast MRI Market Revenue, 2011 - 2019  (USD Million)
FIG. 10 Global Breast Ultrasound Market Revenue, 2011 – 2019 (USD Million)
FIG. 11 Global Tomosynthesis Market Revenue, 2011 – 2019 (USD Million)
FIG. 12 Global Nuclear Imaging Market Revenue, 2011 – 2019 (USD Million)
FIG. 13 Global Other Breast Imaging Technologies Market Revenue, 2011 – 2019 (USD Million)
FIG. 14 North America Breast Imaging Market Revenue, 2011 - 2019 (USD Million)
FIG. 15 Europe Breast Imaging Market Revenue, 2011 - 2019 (USD Million)
FIG. 16 Asia-Pacific Breast Imaging Market Revenue, 2011 – 2019 (USD Million)
FIG. 17 RoW Breast Imaging Market Revenue, 2011 - 2019 (USD Million)
FIG. 18 SonoSite, Inc.* : Annual Revenue, 2010 – 2011 (USD Million)
FIG. 19 GE Healthcare: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 20 Hologic, Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 21 Philips Healthcare: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 22 Siemens Healthcare: Annual Revenue, 2010 – 2012 (USD Million)

List of Tables

TABLE 1 Market Snapshot: Global Breast Imaging Market
TABLE 2 Global Breast Imaging Market Revenue, by Technology, 2011 – 2019 (USD Million)
TABLE 3 Global Breast Imaging Market Revenue, by Geography, 2011 - 2019 (USD Million)
TABLE 4 North America Breast Imaging Market Revenue, by Technology, 2011 - 2019 (USD Million)
TABLE 5 Europe Breast Imaging Market Revenue, by Technology, 2011 - 2019 (USD Million)
TABLE 6 Asia-Pacific Breast Imaging Market Revenue, by Technology, 2011 - 2019 (USD Million)
TABLE 7 RoW Breast Imaging Market Revenue, by Technology, 2011 - 2019 (USD Million)

Free Market Analysis


Globally, breast cancer is one of the most commonly diagnosed forms of cancer and is among the leading causes of cancer death in women. Since the last decade, high prevalence of breast cancer has been observed worldwide and the morbidity rate is rapidly growing. The global female population with age more than 40 years and those on hormone replacement therapy (HRT) are at a higher risk of breast cancer, and thus, aging of population is one of the major factors that has increased the incidence rate of breast cancer worldwide. 

It has been observed that the morbidity rate of breast cancer is higher in developed countries, whereas high mortality rate is noticed in less-developed nations with low financial resources. According to the International Prevention Research Institute (iPRI) in France, in high income countries, not many women are diagnosed with late stage (stage III or IV) breast cancer. However, in low income countries, majority of the women diagnosed with breast cancer were at the later stage of the disease. Thus, it has been realized by the governments of less-developed countries and international healthcare organizations that intensive efforts need to be taken in order to ensure that women in such countries receive early and better solutions for breast cancer diagnosis. Factors such as increase in population size, large pool of geriatric female population, longer life expectancy, increase in awareness, and introduction of early diagnosis programs by governments and healthcare societies are the major contributors to the improving rate of breast cancer diagnosis.

Though various technologies such as, mammography, breast MRI, breast ultrasound, nuclear imaging and tomosynthesis are available in the market for breast cancer diagnosis, mammography is considered as a standard diagnostic tool. Mammography involves the use of low dose of X-rays to obtain two dimensional images of breast tissues. It has been reported that, each year, approximately 44 million women in the U.S. undergo mammography and out of those, 36% women are referred for a second diagnostic test. Many of such women are referred to ultrasound breast screening. Ultrasound is viewed as a promising method of cancer detection among women with dense breasts.

Breast MRI technique uses magnetic waves to capture breast tissue images, while ultrasound uses sound waves with a frequency higher than the human hearing range. Majority of the breast MRI tools use a contrast agent, gadolinium-DPTA. Today, MRI is used for the detection of a wide variety of breast conditions. Their specificity in tumor detection has led to MRI being one of the leading breast cancer detection tools. Nuclear imaging tools such as positron emission tomography (PET) is used for restaging and evaluation of recurrent breast cancer. A number of PET imaging tools are available in the market and their advanced variants are currently under development to determine their efficacy. Commonly used radioactive tracers in nuclear medicine-based breast imaging solutions includeTechnetium-99m (Tc-99m) sestamibi and Fludeoxyglucose (FDG). 

Geographically, North America dominates the global breast imaging market and is followed by Europe. Highly developed healthcare infrastructure and higher rate of awareness are the major factors that contribute to the growth of breast imaging market in these regions. Asia-Pacific is a lucrative market for breast imaging owing to increased incidence of breast cancer screening, mainly in countries like China and India. Contribution of Asian countries to the breast imaging market is expected to further increase as the medical tourism industry rapidly flourishes in this region. 

global-breast-imaging-market-revenue-by-technology-2012

To get discount on this report, just click on the button below.

To receive brochure, please click on the button below.

Share This Market Study!  

Upcoming Report

Payment
Copyright @ Transparency Market Research